Helicobacter pylori regulates TLR4 and TLR9 during gastric carcinogenesis

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 10, 2014, Pages 6950-6955

  Wang, Tian Rong ^a   Peng, Jiang Chen ^a   Qiao, Yu Qi ^a   Zhu, Ming Ming ^a   Zhao, Di ^a   Shen, Jun ^a   Ran, Zhi Hua ^a  

^a School of Medicine   (China)

Author keywords

Expression of Toll like receptor; Gastric carcinogenesis; H. pylori

Indexed keywords

TLR4 PROTEIN, HUMAN; TLR9 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9;

ADOLESCENT; ADULT; AGED; ATROPHY; CASE CONTROL STUDY; CELL TRANSFORMATION; CHEMISTRY; FEMALE; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOST PATHOGEN INTERACTION; HUMAN; HYPERPLASIA; MALE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; PATHOLOGY; STOMACH MUCOSA; STOMACH TUMOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ATROPHY; CASE-CONTROL STUDIES; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOST-PATHOGEN INTERACTIONS; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; STOMACH NEOPLASMS; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9; YOUNG ADULT;

EID: 84912079413     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Suerbaum S and Michetti P. Helicobacter pylori infection. N Engl J Med 2002; 347: 1175-1186.
2. Segal ED, Lange C, Covacci A, Tompkins LS and Falkow S. Induction of host signal transduction pathways by Helicobacter pylori. Proc Natl Acad Sci U S A 1997; 94: 7595-7599.
3. Akira S, Takeda K and Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2: 675-680.
4. Kawai T and Akira S. TLR signaling. Cell Death Differ 2006; 13: 816-825.
5. Underhill DM and Ozinsky A. Toll-like receptors: key mediators of microbe detection. Curr Opin Immunol 2002; 14: 103-110.
6. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001; 1: 135-145.
7. Oldenburg M, Kruger A, Ferstl R, Kaufmann A, Nees G, Sigmund A, Bathke B, Lauterbach H, Suter M, Dreher S, Koedel U, Akira S, Kawai T, Buer J, Wagner H, Bauer S, Hochrein H and Kirschning CJ. TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modification. Science 2012; 337: 1111-1115.
8. Barton GM and Medzhitov R. Toll-like receptor signaling pathways. Science 2003; 300: 1524-1525.
9. Schmausser B, Andrulis M, Endrich S, Lee SK, Josenhans C, Muller-Hermelink HK and Eck M. Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. Clin Exp Immunol 2004; 136: 521-526.
10. Ishihara S, Rumi MA, Kadowaki Y, Ortega-Cava CF, Yuki T, Yoshino N, Miyaoka Y, Kazumori H, Ishimura N, Amano Y and Kinoshita Y. Essential role of MD-2 in TLR4-dependent signaling during Helicobacter pylori-associated gastritis. J Immunol 2004; 173: 1406-1416.
11. Kawahara T, Kuwano Y, Teshima-Kondo S, Kawai T, Nikawa T, Kishi K and Rokutan K. Toll-like receptor 4 regulates gastric pit cell responses to Helicobacter pylori infection. J Med Invest 2001; 48: 190-197.
12. Takeda K and Akira S. Toll-like receptors in innate immunity. Int Immunol 2005; 17: 1-14.
13. Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002; 20: 709-760.
14. Latz E, Schoenemeyer A, Visintin A, Fitzgerald KA, Monks BG, Knetter CF, Lien E, Nilsen NJ, Espevik T and Golenbock DT. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 2004; 5: 190-198.
15. Pimentel-Nunes P, Soares JB, Roncon-Albuquerque R Jr, Dinis-Ribeiro M and Leite-Moreira AF. Toll-like receptors as therapeutic targets in gastrointestinal diseases. Expert Opin Ther Targets 2010; 14: 347-368.
16. Cario E, Rosenberg IM, Brandwein SL, Beck PL, Reinecker HC and Podolsky DK. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol 2000; 164: 966-972.
17. Cario E and Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000; 68: 7010-7017.
18. Fusunyan RD, Nanthakumar NN, Baldeon ME and Walker WA. Evidence for an innate immune response in the immature human intestine: toll-like receptors on fetal enterocytes. Pediatr Res 2001; 49: 589-593.
19. Gewirtz AT, Navas TA, Lyons S, Godowski PJ and Madara JL. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol 2001; 167: 1882-1885.
20. Smith PD, Smythies LE, Mosteller-Barnum M, Sibley DA, Russell MW, Merger M, Sellers MT, Orenstein JM, Shimada T, Graham MF and Ku- bagawa H. Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J Immunol 2001; 167: 2651-2656.
21. Otte JM, Rosenberg IM and Podolsky DK. Intestinal myofibroblasts in innate immune respo- nses of the intestine. Gastroenterology 2003; 124: 1866-1878.
22. Maaser C, Heidemann J, von Eiff C, Lugering A, Spahn TW, Binion DG, Domschke W, Lugering N and Kucharzik T. Human intestinal microvascular endothelial cells express Toll-like receptor 5: a binding partner for bacterial flagellin. J Immunol 2004; 172: 5056-5062.
23. Brandt S, Kwok T, Hartig R, Konig W and Backert S. NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc Natl Acad Sci U S A 2005; 102: 9300-9305.
24. Chang YJ, Wu MS, Lin JT, Sheu BS, Muta T, Inoue H and Chen CC. Induction of cyclooxygenase- 2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-Src-dependent nuclear factor-kappaB activation. Mol Pharmacol 2004; 66: 1465-1477.
25. Murata H, Kawano S, Tsuji S, Tsuji M, Sawaoka H, Kimura Y, Shiozaki H and Hori M. Cyclooxygenase- 2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma. Am J Gastroenterol 1999; 94: 451-455.
26. Xue YW, Zhang QF, Zhu ZB, Wang Q and Fu SB. Expression of cyclooxygenase-2 and clinico pathologic features in human gastric adenocarcinoma. World J Gastroenterol 2003; 9: 250-253.
27. Kitadai Y, Takahashi Y, Haruma K, Naka K, Sumii K, Yokozaki H, Yasui W, Mukaida N, Ohmoto Y, Kajiyama G, Fidler IJ and Tahara E. Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice. Br J Cancer 1999; 81: 647-653.